GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (STU:RV6) » Definitions » 3-Year EPS without NRI Growth Rate

Charles River Laboratories International (STU:RV6) 3-Year EPS without NRI Growth Rate : 8.60% (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Charles River Laboratories International 3-Year EPS without NRI Growth Rate?

Charles River Laboratories International's EPS without NRI for the three months ended in Mar. 2024 was €1.20.

During the past 12 months, Charles River Laboratories International's average EPS without NRI Growth Rate was 15.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 8.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 16.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 17.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Charles River Laboratories International was 41.50% per year. The lowest was -26.50% per year. And the median was 12.75% per year.


Competitive Comparison of Charles River Laboratories International's 3-Year EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Charles River Laboratories International's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International's 3-Year EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's 3-Year EPS without NRI Growth Rate falls into.



Charles River Laboratories International 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Charles River Laboratories International  (STU:RV6) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Charles River Laboratories International 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Charles River Laboratories International (STU:RV6) Business Description

Traded in Other Exchanges
Address
251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Charles River Laboratories International (STU:RV6) Headlines

No Headlines